More

    Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow



    [
    Novo Nordisk cuts 2025 outlook as Wegovy obesity drug sales slow
    [og_img]
    https://www.investing.com/news/stock-market-news/obesity-drugmaker-novo-nordisk-cuts-2025-outlook-posts-q1-profit-above-forecast-4027000


    Reuters

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img